Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Opioid Overdose Deaths Targeted By FDA Technology Competition September 20, 2016 Irvin Jackson Add Your Comments Federal regulators are trying to use a competition to spur technology developers to create an app that helps people experiencing an opioid overdose get access to nearby life saving medication. The 2016 Naloxone App Competition was announced by the FDA on September 19, indicating that the winner will be awarded $40,000, as part of an effort to encourage new technologies that will reduce the risk of narcotic painkiller overdoses. The contest is supported by the National Institute on Drug Abuse (NIDA) and the Substance Abuse and Mental Health Services Administration (SAMHSA). Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “With a dramatic increase in the number of opioid overdose deaths in the U.S., there’s a vital need to harness the power of new technologies to quickly and effectively link individuals experiencing an overdose – or a bystander such as a friend or family member – with someone who carries and can administer the life-saving medication,” FDA Commissioner Robert M. Califf, said in a press release. “Through this competition, we are tapping public health-focused innovators to help bring technological solutions to a real-world problem that is costing the U.S. thousands of lives each year.” In recent years, the opioid overdose epidemic has worsened, affecting more than 2 million Americans who abused or were dependent on prescription narcotic painkillers in 2014 alone. Opioid overdoses increased 137 percent from 2000 to 2015, reaching an all time high in the U.S. Naloxone is a drug used to counteract opioid overdose, saving many lives that would be lost from accidental overdose.It is currently available by prescription and many states have taken steps to make the drug available to first responders, as well as family and friends of opioid users. The number of people given naloxone tripled from 2010 to 2014, according to the CDC. However many of the people who are carrying naloxone are not opioid users, they are simply a concerned family member or friend and won’t be present when an overdose happens. In 2014, approximately 28,000 people died from opioid overdoses. According to a study published in 2015, while opioid abuse was on the decline, more people are dying from narcotic painkiller overdoses than ever before. Some health experts say many could have been saved if users received naloxone to stop or reverse the effects of opioid overdose. Opioid App Contest The FDA is calling on computer programmers, entrepreneurs and innovators in general from all disciplines to create a mobile phone app that can connect opioid users, potentially in the midst of an overdose crisis, to nearby carriers of naloxone, to increase their chance of receiving a dose in a timely manner, and, ultimately, increase their chances of survival. Participants have until October 7, to register for the contest. They will then be given access to background resources, including information about the opioid epidemic, approved formulations of naloxone, public health recommendations for the use of naloxone and FDA guidance on mobile medical application. On October 19 and 20, the FDA will host a two-day code-a-thon. It will be hosted in person on FDA campus and virtually for registered participants. This offers participants a chance to collaborate with other creators, which is encouraged. All code will be made open-source and publicly accessible. Participants can then refine their app and submit a video of a functional prototype, with information on the development and use of the app. The prototype must be submitted by November 7. Judges from the FDA, NIDA and SAMHSA will judge submissions and the highest scoring app will receive an award of $40,000. Following the competition, participants can also apply for NIDA Small Business Innovation Research grants. Tags: Drug Abuse, Drug Overdose, Opioid, Smartphone More Lawsuit Stories Court Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker March 26, 2025 Bard PowerPort Bellwether Trial Selections To Be Made in Late April 2025 March 26, 2025 Lithium-Ion Battery Explosions Could Be Prevented by New Kind of Sensor March 26, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Court Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (Posted: today) A U.S. MORE ABOUT: BIOZORB LAWSUITGroup of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025) Bard PowerPort Bellwether Trial Selections To Be Made in Late April 2025 (Posted: today) Parties have until April 28 to turn in a list of six Bard PowerPort lawsuits that should be prepared for bellwether trials. MORE ABOUT: BARD POWERPORT LAWSUITSmiths Medical Port Catheter Recall Issued Over Manufacturing Error (03/20/2025)E. Coli Infection Was Caused by AngioDynamics SmartPort Port Catheter, Lawsuit Alleges (03/03/2025)Schedule To Prepare Bard PowerPort Lawsuits for Bellwether Trials To Be Proposed by Parties (02/27/2025) Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (Posted: yesterday) A hair relaxer lawsuit claims long-term use of chemical straighteners led to the development of uterine and endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITSchedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)
Court Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (Posted: today) A U.S. MORE ABOUT: BIOZORB LAWSUITGroup of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)
Bard PowerPort Bellwether Trial Selections To Be Made in Late April 2025 (Posted: today) Parties have until April 28 to turn in a list of six Bard PowerPort lawsuits that should be prepared for bellwether trials. MORE ABOUT: BARD POWERPORT LAWSUITSmiths Medical Port Catheter Recall Issued Over Manufacturing Error (03/20/2025)E. Coli Infection Was Caused by AngioDynamics SmartPort Port Catheter, Lawsuit Alleges (03/03/2025)Schedule To Prepare Bard PowerPort Lawsuits for Bellwether Trials To Be Proposed by Parties (02/27/2025)
Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (Posted: yesterday) A hair relaxer lawsuit claims long-term use of chemical straighteners led to the development of uterine and endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITSchedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)